POS-393 PHARMACOKINETICS OF DAPRODUSTAT AND METABOLITES IN SUBJECTS WITH NORMAL AND IMPAIRED HEPATIC FUNCTION

• B. Shaddinger,
• S. Andrews,
• K.M. Mahar,
• B. Ramanjineyulu,
• S. Caltabiano,
• A.C. Lindsay

Affiliations

B. Shaddinger

GSK, Pharma Research & Development - Development Clinical Sciences, Collegeville, United States

S. Andrews

GSK, Pharma Research & Development - Global Clinical Operations, Collegeville, United States

K.M. Mahar

GSK, Pharma Research & Development, Collegeville, United States

B. Ramanjineyulu

GSK, Pharma Research & Development - Development BioStatistics, Bangalore, India

S. Caltabiano

GSK, Pharma Research & Development - Development Clinical Sciences, Collegeville, United States

A.C. Lindsay

GSK, Pharma Research & Development, Collegeville, United States